Sen. Wyden Seeks Federal Investigation Into Anti-Competitive Drug Industry Practices
December 08, 2021
December 08, 2021
WASHINGTON, Dec. 8 -- Sen. Ron Wyden, D-Oregon, issued the following news release:
U.S. Senator Ron Wyden today asked the Federal Trade Commission (FTC) to investigate recent consolidations in Oregon's retail pharmacy market to assess whether large national pharmacy chains and health plans have acted to make this market less competitive.
Wyden's letter to FTC Chair Lina Khan follows the recent announcement by Bi-Mart, a regional chain of pharmacies serving largely non-u . . .
U.S. Senator Ron Wyden today asked the Federal Trade Commission (FTC) to investigate recent consolidations in Oregon's retail pharmacy market to assess whether large national pharmacy chains and health plans have acted to make this market less competitive.
Wyden's letter to FTC Chair Lina Khan follows the recent announcement by Bi-Mart, a regional chain of pharmacies serving largely non-u . . .